TY - JOUR
T1 - Recent contributions to the field of subjective cognitive decline in aging
T2 - A literature review
AU - Munro, Catherine E.
AU - Boyle, Rory
AU - Chen, Xi
AU - Coughlan, Gillian
AU - Gonzalez, Christopher
AU - Jutten, Roos J.
AU - Martinez, Jairo
AU - Orlovsky, Irina
AU - Robinson, Talia
AU - Weizenbaum, Emma
AU - Pluim, Celina F.
AU - Quiroz-Gaviria, Yakeel T.
AU - Gatchel, Jennifer R.
AU - Vannini, Patrizia
AU - Amariglio, Rebecca
N1 - Publisher Copyright:
© 2023 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - Subjective cognitive decline (SCD) is defined as self-experienced, persistent concerns of decline in cognitive capacity in the context of normal performance on objective cognitive measures. Although SCD was initially thought to represent the “worried well,” these concerns can be linked to subtle brain changes prior to changes in objective cognitive performance and, therefore, in some individuals, SCD may represent the early stages of an underlying neurodegenerative disease process (e.g., Alzheimer's disease). The field of SCD research has expanded rapidly over the years, and this review aims to provide an update on new advances in, and contributions to, the field of SCD in key areas and themes identified by researchers in this field as particularly important and impactful. First, we highlight recent studies examining sociodemographic and genetic risk factors for SCD, including explorations of SCD across racial and ethnic minoritized groups, and examinations of sex and gender considerations. Next, we review new findings on relationships between SCD and in vivo markers of pathophysiology, utilizing neuroimaging and biofluid data, as well as associations between SCD and objective cognitive tests and neuropsychiatric measures. Finally, we summarize recent work on interventions for SCD and areas of future growth in the field of SCD.
AB - Subjective cognitive decline (SCD) is defined as self-experienced, persistent concerns of decline in cognitive capacity in the context of normal performance on objective cognitive measures. Although SCD was initially thought to represent the “worried well,” these concerns can be linked to subtle brain changes prior to changes in objective cognitive performance and, therefore, in some individuals, SCD may represent the early stages of an underlying neurodegenerative disease process (e.g., Alzheimer's disease). The field of SCD research has expanded rapidly over the years, and this review aims to provide an update on new advances in, and contributions to, the field of SCD in key areas and themes identified by researchers in this field as particularly important and impactful. First, we highlight recent studies examining sociodemographic and genetic risk factors for SCD, including explorations of SCD across racial and ethnic minoritized groups, and examinations of sex and gender considerations. Next, we review new findings on relationships between SCD and in vivo markers of pathophysiology, utilizing neuroimaging and biofluid data, as well as associations between SCD and objective cognitive tests and neuropsychiatric measures. Finally, we summarize recent work on interventions for SCD and areas of future growth in the field of SCD.
KW - Aging
KW - Alzheimer's disease
KW - subjective cognitive concerns
KW - subjective cognitive decline
KW - subjective cognitive impairment
UR - https://www.scopus.com/pages/publications/85174609743
U2 - 10.1002/dad2.12475
DO - 10.1002/dad2.12475
M3 - Review article
AN - SCOPUS:85174609743
SN - 2352-8729
VL - 15
JO - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
JF - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
IS - 4
M1 - e12475
ER -